Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming
Overview
Authors
Affiliations
Reprogramming of cellular identity using exogenous expression of transcription factors (TFs) is a powerful and exciting tool for tissue engineering, disease modeling, and regenerative medicine. However, generation of desired cell types using this approach is often plagued by inefficiency, slow conversion, and an inability to produce mature functional cells. Here, we show that expression of constitutively active SMAD2/3 significantly improves the efficiency of induced pluripotent stem cell (iPSC) generation by the Yamanaka factors. Mechanistically, SMAD3 interacts with reprogramming factors and co-activators and co-occupies OCT4 target loci during reprogramming. Unexpectedly, active SMAD2/3 also markedly enhances three other TF-mediated direct reprogramming conversions, from B cells to macrophages, myoblasts to adipocytes, and human fibroblasts to neurons, highlighting broad and general roles for SMAD2/3 as cell-reprogramming potentiators. Our results suggest that co-expression of active SMAD2/3 could enhance multiple types of TF-based cell identity conversion and therefore be a powerful tool for cellular engineering.
Nucleosome fibre topology guides transcription factor binding to enhancers.
ODwyer M, Azagury M, Furlong K, Alsheikh A, Hall-Ponsele E, Pinto H Nature. 2024; 638(8049):251-260.
PMID: 39695228 PMC: 11798873. DOI: 10.1038/s41586-024-08333-9.
Role of the TGF-β signaling pathway in induced pluripotent stem cells reprogramming.
Fan W, Yuan H, Chang L, Li Q, Gao J, Ma L Chin Med J (Engl). 2024; .
PMID: 39039625 PMC: 11407801. DOI: 10.1097/CM9.0000000000003229.
Oct4 redox sensitivity potentiates reprogramming and differentiation.
Shen Z, Wu Y, Manna A, Yi C, Cairns B, Evason K Genes Dev. 2024; 38(7-8):308-321.
PMID: 38719541 PMC: 11146590. DOI: 10.1101/gad.351411.123.
H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency.
Kunitomi A, Hirohata R, Osawa M, Washizu K, Arreola V, Saiki N Stem Cell Reports. 2024; 19(5):710-728.
PMID: 38701780 PMC: 11103934. DOI: 10.1016/j.stemcr.2024.04.005.
Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts.
Benarroch L, Madsen-Osterbye J, Abdelhalim M, Mamchaoui K, Ohana J, Bigot A Cells. 2023; 12(15).
PMID: 37566074 PMC: 10417614. DOI: 10.3390/cells12151995.